Jos Jansen

5 127 Screening for abnormal glycosylation in a cohort of adult liver disease patients 17. Wolthuis DF, Janssen MC, Cassiman D, Lefeber DJ, Morava E. Defining the phenotype and diagnostic considerations in adults with congenital disorders of N-linked glycosylation. Expert review of molecular diagnostics. 2014;14(2):217-24. 18. Ng BG, Buckingham KJ, Raymond K, Kircher M, Turner EH, He M, et al. Mosaicism of the UDP- galactose transporter SLC35A2 causes a congenital disorder of glycosylation. American journal of human genetics. 2013;92(4):632-6. 19. Westphal V, Kjaergaard S, Davis JA, Peterson SM, Skovby F, Freeze HH. Genetic and metabolic analysis of the first adult with congenital disorder of glycosylation type Ib: long-term outcome and effects of mannose supplementation. Molecular genetics and metabolism. 2001;73(1):77-85. 20. Martinez-Duncker I, Dupre T, Piller V, Piller F, Candelier JJ, Trichet C, et al. Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter. Blood. 2005;105(7):2671-6. 21. Scobell RR, Kaplan BS, Copelovitch L. New insights into the pathogenesis of Streptococcus pneumoniae-associated hemolytic uremic syndrome. Pediatric nephrology. 2019. 22. DiMartini A, Day N, Lane T, Beisler AT, Dew MA, Anton R. Carbohydrate deficient transferrin in abstaining patients with end-stage liver disease. Alcoholism, clinical and experimental research. 2001;25(12):1729-33. 23. Flahaut C, Michalski JC, Danel T, Humbert MH, Klein A. The effects of ethanol on the glycosylation of human transferrin. Glycobiology. 2003;13(3):191-8. 24. Cottalasso D, Domenicotti C, Traverso N, Pronzato M, Nanni G. Influence of chronic ethanol consumption on toxic effects of 1,2-dichloroethane: glycolipoprotein retention and impairment of dolichol concentration in rat liver microsomes and Golgi apparatus. Toxicology. 2002;178(3):229- 40. 25. Gong M, Garige M, Hirsch K, Lakshman MR. Liver Galbeta1,4GlcNAc alpha2,6-sialyltransferase is down-regulated in human alcoholics: possible cause for the appearance of asialoconjugates. Metabolism: clinical and experimental. 2007;56(9):1241-7. 26. Ghosh P, Liu QH, Lakshman MR. Long-term ethanol exposure impairs glycosylation of both N- and O-glycosylated proteins in rat liver. Metabolism: clinical and experimental. 1995;44(7):890-8. 27. Pompach P, Brnakova Z, Sanda M, Wu J, Edwards N, Goldman R. Site-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma. Molecular & cellular proteomics : MCP. 2013;12(5):1281-93. 28. Zhang D, Huang J, Luo D, Feng X, Liu Y, Liu Y. Glycosylation change of alpha-1-acid glycoprotein as a serum biomarker for hepatocellular carcinoma and cirrhosis. Biomark Med. 2017;11(5):423-30. 29. Huang Y, Zhou S, Zhu J, Lubman DM, Mechref Y. LC-MS/MS isomeric profiling of permethylated N-glycans derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients. Electrophoresis. 2017;38(17):2160-7. 30. Verhelst X, Dias AM, Colombel JF, Vermeire S, Van Vlierberghe H, Callewaert N, et al. Protein Glycosylation as a Diagnostic and Prognostic Marker of Chronic Inflammatory Gastrointestinal and Liver Diseases. Gastroenterology. 2020;158(1):95-110. 31. Sato Y, Nakata K, Kato Y, Shima M, Ishii N, Koji T, et al. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. The New England journal of medicine. 1993;328(25):1802-6. 32. Landberg E, Astrom E, Kagedal B, Pahlsson P. Disialo-trisialo bridging of transferrin is due to increased branching and fucosylation of the carbohydrate moiety. Clinica chimica acta; international journal of clinical chemistry. 2012;414:58-64.